UK Statutory Instrument SI 1993/2538 United Kingdom

The Medicines (Applications for Grant of Product Licences—Products for Human Use) Regulations 1993

Status
In Force

What it defines

Regulations creating concrete business duties or carrying penalties, grouped as the instrument is structured. Titles link to the source text — blue means you’re leaving for legislation.gov.uk.

5 other provisions — procedural and definitional
s.001 Citation, commencement and interpretation
s.002 Application of these Regulations
s.003 Manner of applications
s.004 Material to be contained in or accompany an application
s.005 Amendment of the Medicines (Applications for Product Licences and Clinical Trial and Animal Test Certificates) Regulations 1971
Schedules

Schedules

0 of 33 shown
33 other schedules
s.sch001 (a) The name or corporate name of and the permanent...
s.sch001 A copy of the manufacturing authorisation as defined in Article...
s.sch001 A copy of any authorisation obtained in a member State...
s.sch001 An expert’s report (stating, where applicable, the grounds for using...
s.sch001 Brief information about the educational background, training and occupational experience...
s.sch001 One or more samples or mock-ups of the sales presentation,...
s.sch001 A statement of the number of volumes of documentation submitted...
s.sch001 A statement as to any samples provided.
s.sch001 Where the applicant is, by virtue of paragraph 8 above,...
s.sch001 Where the applicant is, by virtue of paragraph 8 above,...
s.sch001 A statement indicating— (a) which of the following should apply...
s.sch001 The name of the product, that is to say, the...
s.sch001 If the product is already authorised in other countries—
s.sch001 In relation to any generator to which Article 3 of...
s.sch001 Where the applicant, in relation to all or any particular...
s.sch001 Where the licence applied for is required solely for the...
s.sch001 A statement indicating that the applicant agrees that the licence...
s.sch001 All other information which is relevant to the evaluation of...
s.sch001 The qualitative and quantitative particulars of all the constituents of...
s.sch001 A brief description of the method of preparation.
s.sch001 Particulars of the therapeutic indications, contra-indications and side-effects.
s.sch001 Particulars of the posology, pharmaceutical form, method and route of...
s.sch001 A description, drawn up and signed by experts, of the...
s.sch001 Subject to Schedule 2, particulars, drawn up and signed by...
s.sch001 A summary of the product characteristics which shall contain the...
s.sch002 Subject to paragraphs 2 to 4 below, the applicant shall...
s.sch002 Notwithstanding paragraph 1 above, the applicant shall provide particulars of...
s.sch002 Where the product is a new medicinal product containing known...
s.sch002 The applicant shall not be entitled by virtue of the...
s.sch002 Subject to compliance with paragraphs 19(a) and 22 of Schedule...
s.sch002 The applicant shall not be required under paragraph 8 of...
s.sch003 In the case of— (a) an active ingredient not described...
s.sch003 Paragraph 1 of this Schedule shall not apply unless the...

Duty extraction and severity labels are Guvnor’s analysis of the instrument, not the instrument itself. Always verify against the linked source text.